KOSPI Hits All-Time High After Dramatic V-Shaped Recovery Led by SK Hynix and Alteogen

The South Korean stock market reached a record high on June 17, 2026, following a volatile trading session that saw the KOSPI index recover from an initial 104-point drop. Despite a massive 992.5 billion won sell-off by foreign investors, a combined 1.12 trillion won purchase from domestic institutions and individual investors pushed the index to a closing record of 8,864.24, according to data from the Korea Exchange.

Did You Know? The KOSPI index experienced a dramatic 240-point swing during the June 17 session, opening at 8,622.13 before climbing to a daily high of 8,726.60 and eventually closing at an all-time high of 8,864.24.

What drove the market recovery?

The market turnaround was primarily fueled by significant gains in the semiconductor and biotechnology sectors. SK Hynix saw its shares surge 5.84%, while SK Square rose 6.33%, providing essential momentum for the KOSPI’s record-breaking performance. According to market reports, the rally was bolstered by institutional investors who net-bought 580 billion won and individual investors who contributed 540 billion won in buying power, effectively absorbing the sell-off pressure initiated by foreign entities.

How did sector performance vary?

While technology and bio-stocks led the gains, other large-cap companies showed mixed results. Samsung Electronics rose 1.02%, and Samsung Life Insurance climbed 3.71%, contributing to the index’s upward trajectory. Conversely, some stocks faced downward pressure due to profit-taking, with Hyundai Motor falling 3.44% and Samsung Electro-Mechanics declining 0.78% by the market close.

Expert Insight: Samantha Carter notes that the market’s ability to absorb nearly 1 trillion won in foreign selling suggests a significant shift in domestic liquidity. The “V-shaped” recovery indicates that institutional and retail investors are currently prioritizing long-term growth in the semiconductor and biotech sectors over short-term macroeconomic concerns.

What is the outlook for the KOSPI and KOSDAQ?

The KOSDAQ index also finished higher, rising 1.30% to close at 1,031.96, supported by a 5.82% jump in shares of the biotechnology firm Alteogen. Analysts suggest that if the current support levels hold, the breakthrough of the 8,800-point threshold could lead to a broader re-rating of South Korean market valuations. Future performance may depend on whether the domestic “buy-side” momentum can continue to offset potential foreign capital outflows stemming from lingering global macroeconomic noise.

Are leveraged ETFs distorting the market? CSOP CEO defends ETF tracking SK Hynix

Frequently Asked Questions

What was the primary cause of the market volatility on June 17?
The volatility was attributed to macroeconomic noise originating from the United States combined with profit-taking pressure on technology stocks, which caused the KOSPI to open 104.47 points lower.

Who were the primary buyers during the market rebound?
Domestic institutions and individual investors acted as the primary buyers, purchasing a combined total of 1.12 trillion won in shares to counteract the 992.5 billion won sold by foreign investors.

Which sectors led the growth on the KOSDAQ?
The biotechnology sector led the KOSDAQ, with Alteogen rising 5.82%, alongside gains from other companies such as Kolon TissueGene, HLB, and Samchundang Pharm.

How do you view the resilience of the domestic market against large-scale foreign selling?